Clinical Trial: This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis

U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07303790) titled 'This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis' on Dec. 09.

Brief Summary: This is an early exploratory study to assess the tolerability and safety of GC012F CAR T cell injection in Multiple Sclerosis patients.

Study Start Date: Jan. 20, 2026

Study Type: INTERVENTIONAL

Condition: Multiple Sclerosis

Intervention: DRUG: GC012F CAR-T Cell Injection

A single dose group is planned for the CAR-T cell infusion dose is administrated for each subject.Single IV infusion.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Daishi Tian

Information provided by (Respons...